DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Raised to $21.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price boosted by Barrington Research from $20.00 to $21.00 in a research report sent to investors on Monday morning,Benzinga reports. The brokerage currently has an outperform rating on the medical instruments supplier’s stock. Barrington Research also issued estimates for DENTSPLY SIRONA’s Q2 2025 earnings at $0.51 EPS, Q3 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.47 EPS, FY2025 earnings at $1.90 EPS, Q1 2026 earnings at $0.46 EPS, Q2 2026 earnings at $0.55 EPS, Q3 2026 earnings at $0.55 EPS, Q4 2026 earnings at $0.54 EPS, FY2026 earnings at $2.10 EPS and FY2027 earnings at $2.28 EPS.

Several other analysts also recently commented on the stock. UBS Group cut their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, May 9th. Wells Fargo & Company dropped their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating on the stock in a report on Friday, February 28th. StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Morgan Stanley downgraded shares of DENTSPLY SIRONA from an “overweight” rating to an “equal weight” rating and set a $14.00 price target on the stock. in a report on Tuesday, April 15th. Finally, Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price target for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $20.36.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $16.45 on Monday. DENTSPLY SIRONA has a one year low of $12.16 and a one year high of $28.50. The company’s 50-day moving average is $14.38 and its 200 day moving average is $17.48. The company has a market capitalization of $3.28 billion, a price-to-earnings ratio of -7.95, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $879.00 million for the quarter, compared to the consensus estimate of $854.75 million. During the same period in the prior year, the firm posted $0.42 EPS. DENTSPLY SIRONA’s revenue for the quarter was down 7.8% on a year-over-year basis. Sell-side analysts expect that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 3.89%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.10%.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction dated Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at approximately $1,353,341.21. This trade represents a 22.66% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Company insiders own 0.50% of the company’s stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors have recently made changes to their positions in XRAY. Vanguard Group Inc. raised its stake in DENTSPLY SIRONA by 2.8% during the 1st quarter. Vanguard Group Inc. now owns 20,740,589 shares of the medical instruments supplier’s stock worth $309,864,000 after acquiring an additional 557,329 shares during the period. First Eagle Investment Management LLC raised its stake in DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier’s stock worth $275,218,000 after acquiring an additional 348,532 shares during the period. Price T Rowe Associates Inc. MD raised its stake in DENTSPLY SIRONA by 11.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 13,961,759 shares of the medical instruments supplier’s stock worth $208,590,000 after acquiring an additional 1,412,517 shares during the period. Nuance Investments LLC raised its stake in DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the period. Finally, Fuller & Thaler Asset Management Inc. raised its stake in DENTSPLY SIRONA by 4.7% during the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 12,077,949 shares of the medical instruments supplier’s stock worth $180,445,000 after acquiring an additional 538,531 shares during the period. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.